STERIS reports flat Q2 revenue, adjusted EPS $1.99, $490.6M dental impairment

STERIS plc

2023-Q2 EPS reported -$2.04 revenue$2,357,008,000

Revenue flat at $1.2B; constant currency organic revenue grew 7% YoY.
GAAP loss per share ($3.15) due to $490.6M dental impairment; adjusted EPS $1.99.
Dental segment impairment charge of $490.6M recorded in the quarter.
Fiscal 2023 second quarter ended September 30, 2022 results announced November 9, 2022.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

STERIS plc reported fiscal 2023 second quarter ended September 30, 2022 results: revenue $1.2 billion, EPS as reported loss per share of ($3.15); adjusted EPS of $1.99.

Period: fiscal 2023 second quarter ended September 30, 2022
Revenue: $1.2 billion
EPS: as reported loss per share of ($3.15); adjusted EPS of $1.99
Result: reported results

Exact text from the filing

STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2023 second quarter ended September 30, 2022. Revenue as reported for the quarter was flat at $1.2 billion compared with $1.2 billion in the second quarter of fiscal 2022. Constant currency organic revenue (see

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

STERIS plc filing history →

Source: SEC EDGAR

accession 0001757898-22-000020

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.